Hainan Haiyao Co. Ltd. (000566)

Overview

Hainan Haiyao Co., Ltd., established in 1965 and headquartered in Haikou, China, operates within the pharmaceutical sector, engaging in the manufacturing and international sale of pharmaceutical products and medical devices. Distinguished by its dedication to innovation and quality, the company stands as a significant player in various segments of the healthcare industry, including the development of intermediates, Active Pharmaceutical Ingredients (APIs), innovative chemical drugs, modern Chinese medicines, biological drugs, cellular immunity products, and high-end medical devices. Its extensive product range addresses a wide spectrum of healthcare needs, reinforcing its position in both domestic and international markets.

Products and Services

• Pharmaceutical Products: This category encompasses a vast assortment of medications and health products, including antibiotics, gastrointestinal medicines, and anti-tumor drugs. The products are presented in various forms—from pills and tablets to granules and powders, catering to different therapeutic areas.
• Vitamin C for Injection: Specifically designed for conditions like scurvy and idiopathic methemoglobinemia, this product highlights the company's commitment to addressing niche medical needs through scientific innovation.
• Medical Devices: Specializing in high-end medical devices, the company contributes to the healthcare industry with technological advancements. A notable offering in this category is the cochlear implant series, designed to provide solutions for individuals with hearing impairments.
• Health Foods: Catering to the growing market for nutritional supplements and health-related food products, this line signifies the company's move towards holistic health, offering options for those seeking wellness through dietary enhancements.
• Modern Chinese Medicines: These products combine traditional Chinese medicinal practices with modern scientific approaches, offering treatments that respect cultural heritage while incorporating contemporary pharmaceutical innovations.
• Biological Drugs and Cellular Immunity Products: With an emphasis on cutting-edge research, this segment includes innovative treatments developed through biotechnological methods, focusing on diseases where traditional medication may fall short.
• Internet Medical Treatment and Medical Services: In response to the digital transformation of healthcare, Hainan Haiyao Co., Ltd. offers online medical services. This approach not only broadens their service portfolio but also enhances accessibility and convenience for patients seeking medical advice and treatment.